APOH Human Pre-designed siRNA Set A contains three designed siRNAs for APOH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOL1 Human Pre-designed siRNA Set A contains three designed siRNAs for APOL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOL2 Human Pre-designed siRNA Set A contains three designed siRNAs for APOL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOL3 Human Pre-designed siRNA Set A contains three designed siRNAs for APOL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOL4 Human Pre-designed siRNA Set A contains three designed siRNAs for APOL4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOL5 Human Pre-designed siRNA Set A contains three designed siRNAs for APOL5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOL6 Human Pre-designed siRNA Set A contains three designed siRNAs for APOL6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOLD1 Human Pre-designed siRNA Set A contains three designed siRNAs for APOLD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOM Human Pre-designed siRNA Set A contains three designed siRNAs for APOM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Apomine (SR-45023A) is an antineoplastic agent that inhibits the mevalonate/isoprenoid pathway in cholesterol synthesis. It can accelerate the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR). Apomine can also inhibit the growth of various types of cancer cells, including lung cancer, colon cancer, breast cancer, and skin cancer. In addition, Apomine is able to induce apoptosis in tumor […]

APOO Human Pre-designed siRNA Set A contains three designed siRNAs for APOO gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APOOL Human Pre-designed siRNA Set A contains three designed siRNAs for APOOL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Apoptosis inducer 15 (Compound 3) induces cell apoptosis and cell cycle arrest at G2/M phase. Apoptosis inducer 15 is cytotoxicitic without causing DNA fragmentation[1].

Apoptosis inducer 16 (Compound 3) is a bivalent Smac mimic that can effectively bind to BIR2 and BIR3, and exhibits cancer cell apoptosis (apoptosis) inducing activity[1].

Apoptosis inducer 17 is a Curcumin-Piperlongumine hybrid molecule that increases cell cycle arrest and apoptosis through activating JNK signaling pathway in lung cancer cells[1].

Apoptotic agent-4 (Compound 9) is a apoptosis inducer. Apoptotic agent-4 inhibits VEGFR-2 with an IC50 of 0.5717 μM. Apoptotic agent-4 inhibits cancer cell proliferation and arrests the cell at both the G2/M and Pre-G1 phases[1].

APP Human Pre-designed siRNA Set A contains three designed siRNAs for APP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

App Mouse Pre-designed siRNA Set A contains three designed siRNAs for App gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

App Rat Pre-designed siRNA Set A contains three designed siRNAs for App gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

APPBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for APPBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APPL1 Human Pre-designed siRNA Set A contains three designed siRNAs for APPL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APPL2 Human Pre-designed siRNA Set A contains three designed siRNAs for APPL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Aprepitant (Standard) is the analytical standard of Aprepitant. This product is intended for research and analytical applications. Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.

Aprindine is an arrhythmia inhibitor that stabilizes the cell membranes of heart muscle cells, thereby preventing abnormal electrical impulses from causing irregular heartbeats. In hematological toxicity studies, aprindine showed potential inhibitory effects on the replicative capacity of mouse and human blood cells at certain concentrations[1].

APRT Human Pre-designed siRNA Set A contains three designed siRNAs for APRT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

APTX Human Pre-designed siRNA Set A contains three designed siRNAs for APTX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP1 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP10 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP11 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP2 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP3 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP3-IN-1 (compounds 3) is an AQP3 inhibitor with a IC50 value of 8.91 μM. AQP3-IN-1 inhibits cell proliferation of melanoma cells[1].

AQP4 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP5 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP6 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP7 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP8 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQP9 Human Pre-designed siRNA Set A contains three designed siRNAs for AQP9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

AQR Human Pre-designed siRNA Set A contains three designed siRNAs for AQR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.